dihydroxyphenylalanine has been researched along with trifluoperazine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keegan, DL; Rajput, AH | 1 |
| Barkhatova, VP; Gotovtseva, EV; Ivanova-Smolenskaia, IA; Markova, ED; Tkachev, RA | 1 |
| Thörner, R; Zetler, G | 1 |
| Dana, L; Merlis, S; Wolpert, A; Yaryura-Tobias, JA | 1 |
| Jenkins, R | 1 |
| Katz, MH; Krop, S; Yen, HC | 1 |
| LAVERTY, R; SHARMAN, DF | 1 |
| Chikobava, EA; Galenko-Yaroshevskii, PA; Gurskaya, EV; Sukoyan, GV | 1 |
8 other study(ies) available for dihydroxyphenylalanine and trifluoperazine
| Article | Year |
|---|---|
Drug induced dystonia tarda: treatment with L-dopa.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Diazepam; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Evaluation Studies as Topic; Female; Humans; Middle Aged; Schizophrenia; Thioridazine; Trifluoperazine | 1973 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Hyperkinesis; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease; Penicillamine; Phenothiazines; Pyridoxine; Sulfhydryl Compounds; Trifluoperazine; Tropanes | 1973 |
Drug-induced catalepsy as influenced by psychostimulants, apomorphine, L-dopa, and yohimbine.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Dihydroxyphenylalanine; Hallucinogens; Haloperidol; Humans; Male; Mecamylamine; Mice; Mice, Inbred Strains; Nicotine; Paraoxon; Pempidine; Phenmetrazine; Pilocarpine; Sparteine; Tetrabenazine; Trifluoperazine; Yohimbine | 1973 |
Action of L-Dopa in drug induced extrapyramidalism.
Topics: Adult; Chlorpromazine; Chronic Disease; Dihydroxyphenylalanine; Extrapyramidal Tracts; Female; Humans; Male; Middle Aged; Movement Disorders; Perphenazine; Schizophrenia; Smoking; Trifluoperazine; Trihexyphenidyl | 1970 |
Laevo-dopa for Parkinsonism.
Topics: Dihydroxyphenylalanine; Haloperidol; Humans; Parkinson Disease; Trifluoperazine | 1970 |
Effects of various drugs on 3,4-dihydroxyphenylalanine (DL-DOPA)-induced excitation (agressive behavior) in mice.
Topics: Aggression; Animals; Antidepressive Agents; Autonomic Agents; Behavior, Animal; Bretylium Compounds; Chlordiazepoxide; Chlorpromazine; Diazepam; Dihydroxyphenylalanine; Drug Antagonism; Haloperidol; Hexobarbital; Humans; Imipramine; Iproniazid; Male; Mice; Morphine; Oxazepam; Reserpine; Tranquilizing Agents; Tranylcypromine; Trifluoperazine | 1970 |
MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.
Topics: Animals; Atropine; Behavior, Animal; Brain; Brain Chemistry; Cats; Caudate Nucleus; Cerebral Cortex; Chlorpromazine; Chromatography; Dextroamphetamine; Dihydroxyphenylalanine; Dogs; Dopamine; Ephedrine; Fluorometry; Guanethidine; Morphine; Norepinephrine; Parasympatholytics; Parkinsonian Disorders; Pharmacology; Phenobarbital; Proteins; Rabbits; Radiometry; Research; Reserpine; Serotonin; Thalamus; Thioridazine; Trifluoperazine; Tritium | 1965 |
Anticataleptic effect of energostim during single treatment with trifluoperazine.
Topics: Animals; Antioxidants; Antipsychotic Agents; Catalepsy; Dihydroxyphenylalanine; Dopamine; Epinephrine; Male; Medulla Oblongata; Norepinephrine; Rats; Substantia Nigra; Trifluoperazine | 2004 |